Subsequent events (Details)	Apr. 28, 2017 USD ($) $ / shares shares	Apr. 17, 2017 USD ($)	Apr. 13, 2017 USD ($)
Subsequent events Details
Mentor entered into an agreement to provide funding to offset costs of the application			$ 40,000
Shareholders hold Series B Warrants		$ 3,000,000
Shareholders hold Series B Warrants will receive per warrant redemption payment		0.1
Company invested an additional in Electrum by purchase of a second promissory note	$ 100,000
Purchase of a second promissory note in principal face amount	$ 100,000
Electrum with interest per annum compounded monthly	10.00%
Monthly principal and interest payments to the Company	$ 2,290
Fixed equity conversion rate per share | $ / shares	$ 164
Electrum to allow interest only payments to continue until Mentor determines	$ 898
Monthly payments of principal and interest per month	2,124
Company increased the total amount invested in G Farma from $500,000	600,000
Increasing the principal face amount of the working capital note by $100,000 to	480,000
Monthly principal and interest payments on the working capital note will increase from $3,505 per month to	4,427
Payments for services provided under the Consulting Agreement will increase from 1,400 per month to	$ 1,680
Farma also purchased an additional shares of Company Common Stock | shares	66,667
Farma also purchased an additional shares of Company Common Stock at per share | $ / shares	$ 1.5
Farma also purchased an additional shares of Company Common Stock for an additional payable | shares	100,000
Company received from warrant redemptions	$ 98,358